-

Viz.ai Appoints Jallel Harrati as Chief Revenue Officer to Accelerate Enterprise Growth

Drawing on leadership experiences at Suki, IBM, and Philips, Harrati will help deepen the adoption of Viz.ai’s products across its health system partners

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the appointment of Jallel Harrati as Chief Revenue Officer (CRO). Harrati joins Viz.ai at an exciting stage as the company scales adoption of Viz Assist, its multimodal AI agent platform, across an established base of 2,000 hospitals.

Viz.ai has long been the leader in building and deploying AI Care Pathways that help ensure more patients receive guideline-based treatment, and hospitals increase clinical and financial efficiency. The recent addition of Viz Assist expands Viz.ai into helping doctors and clinical teams do their work. Viz Assist aims to help clinicians work faster, coordinate better, and focus more on patient care by delivering ambient listening, chart summaries, guideline assistance and coding recommendations in one seamless experience. In his role, Harrati will lead all revenue-generating functions for Viz.ai’s provider business, including sales, customer success, and sales operations.

“Jallel brings a rare combination of strategic vision, deep healthcare industry expertise, and a proven track record of scaling world-class commercial organizations,” said Chris Mansi, MD, CEO and co-founder of Viz.ai. “We are seeing accelerating demand for the broader Viz Platform, which helps reduce variability in care through our AI Care Pathways, and helps doctors and their teams do their work, through Viz Assist. It is a very exciting time to welcome such world class sales leadership to the company.”

Harrati comes to Viz.ai with more than 20 years of commercial leadership experience in healthcare and enterprise technology. Most recently, he served as SVP and GM of New Business Development at Suki. Over a six-year tenure, he built the commercial organization from the ground up and was instrumental in pioneering the market for AI-driven clinical solutions, scaling enterprise adoption across major health systems. Harrati also previously held senior leadership roles at IBM and Philips Healthcare, where he led sales and growth initiatives across AI, analytics, and provider-focused platforms.

“I’m joining Viz.ai at a moment of clear momentum,” said Harrati. “Viz.ai’s differentiated platform is delivering measurable value to health systems, clinicians, and patients, and Viz Assist creates an opportunity to standardize how care teams act on critical, real-time clinical insights. I’m excited to help scale this impact with this world-class team, accelerate growth and build a durable, category-leading business.”

Harrati’s appointment underscores Viz.ai’s focus on scaling its enterprise AI platform to transform clinical care in the hospital; reducing variability, improving outcomes, and reducing cost. With Viz Assist and a portfolio of over 50 AI Care Pathways and growing, Viz.ai is positioned as the defining agentic AI platform for healthcare.

About Viz.ai

Viz.ai is the leader in building and deploying AI-powered Care Pathways and helping doctors do their work. The Viz Platform is deployed in 2,000 hospitals across the United States and trusted by many of the leading life sciences companies. The platform uniquely combines real-time, multimodal clinical data with deep clinician engagement to detect disease earlier, coordinate care teams, and help ensure patients receive the right treatment faster. Viz.ai was the first company awarded CMS reimbursement for AI and is ranked the #1 Healthcare AI Platform by hospitals and health systems in the Black Book Research survey. For more information, visit Viz.ai.

Contacts

Media Contact
Caroline Rueve
viz.ai@solcomms.co

Viz.ai


Release Versions

Contacts

Media Contact
Caroline Rueve
viz.ai@solcomms.co

Social Media Profiles
More News From Viz.ai

Viz.ai Announces Strategic Collaboration to Expand Access to AI-Powered Subdural Hemorrhage Care

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a strategic commercialization collaboration with Johnson & Johnson to expand access to Viz.ai’s Subdural Hemorrhage software solution across hospitals in the United States for automated detection, labeling and quantification of subdural collections. By integrating the Viz Subdural solution into its neurovascular offerings, the company aims to support hospital...

Viz.ai Wins Gold Edison Award™ for Advancing AI-Driven Clinical Workflows to Improve Hemorrhage Care

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that it won the Gold Edison Award 2026 for its AI-powered Viz Hemorrhage solution. This marks the company’s fourth Edison Award and reinforces Viz.ai’s leadership in building the agentic infrastructure that enables artificial intelligence to operate directly within hospitals. Viz.ai was recognized in the Health, Medical & Biotech category for its groundbreaki...

Viz.ai Earns Back-to-Back No. 1 Ranking in Black Book Survey of AI Clinical Decision Support Solutions

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced it has been ranked No. 1 in the Black Book Research survey of AI Clinical Decision Support solutions for the second consecutive year. Based on direct feedback from 1,237 healthcare professionals, including clinicians, administrators, and operational leaders across hospitals, health systems, and medical groups, the annual Black Book survey evaluates vendors on ent...
Back to Newsroom